Nanocrystalline silver (Acticoat) for itch relief in the burns patient [1]

ANZ Journal of Surgery

Volumn 77, Issue 9, 2007, Pages 797-

  Brooks, Peter ^a   Phang, Kian L ^a   Moazzam, Amber ^a  

^a MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTICOAT; ANTIINFLAMMATORY AGENT; NANOCRYSTALLINE SILVER; UNCLASSIFIED DRUG;

BURN PATIENT; CLINICAL ARTICLE; HOSPITAL PATIENT; HUMAN; LETTER; OUTPATIENT; PRURITUS; VISUAL ANALOG SCALE;

ADULT; BANDAGES; BURNS; CHILD; DERMATOLOGIC AGENTS; HUMANS; POLYESTERS; POLYETHYLENES; PRURITUS;

EID: 34547681202     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04233.x     Document Type: Letter

References (4)

1. Vitale M, Fields-Blache C, Luterman A. Severe itching in the patient with burns. J. Burn Care Rehab. 1991 12 : 330 33.
2. Baker RA, Zeller RA, Klein RL et al. Burn wound itch control using H1 and H2 antagonists. J. Burn Care Rehab. 2001 22 : 263 8.
3. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. [Review] [37 refs]. Burns 2004 30 : S1 9.
4. Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin. Exp. Dermatol. 2004 29 : 282 7.